Thursday, August 18, 2016 9:30:23 PM
1) Novartis submits a plan to sell all its holdings in Momenta 3 weeks prior to a 'at risk' launch. I assume they are doing this because their vault is so full they can't shut the door now.
2) It will only take 4 months or less to get through the court system and get a reply. Teva lives in the courts and sometimes their lunch breaks last longer than 4 months. Of course Momenta has a legal team with a perfect record : Zip for ever.
3) Momenta over the last 10 years has rewarded its stockholders with a -22% return. Not bad considering the Naz only went up a meager 155% over the same time period. (We won't even consider the IBB is up 350%)
4) Lastly, we're going to make assumptions about at-risk or not without even knowing who our competition will be. Will we go at risk with 1 or 2 other entrants? Mylan feels they might get 180 day exclusivity? Will they?
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM